Enhanced NT-3 serum levels in severe forms of SLE could reflect a link between NT-3 and lupus flare, in that complement activation (decrease of CH 50 levels) correlates with elevated NT-3 levels. This evidence concerns the gene SORT1 and systemic lupus erythematosus.